Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun:9:e2300040.
doi: 10.1200/GO.23.00040.

Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial

Daphne Day  1   2 , Han Chong Toh  3 , Raghib Ali  4 , Estelle Mei Jye Foo  3 , John Simes  5 , John Whay Kuang Chia  3 , Eva Segelov  1   6 ; ASCOLT Investigators
Affiliations

Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial

Daphne Day et al. JCO Glob Oncol. 2023 Jun.

Abstract

Purpose: The Asia-Pacific (APAC) region is a major focus for multinational clinical trials, although its cultural, linguistic, economic, and regulatory diversity pose significant challenges for trial conduct, particularly for academic clinical trials.

Methods: We describe our experience running the investigator-initiated phase III randomized, fully accrued, Aspirin for Dukes C and high-risk Dukes B Colorectal cancer trial (ASCOLT, ClinicalTrials.gov identifier: NCT00565708, N = 1,587), studying the benefit of aspirin in resected high-risk colorectal cancer. ASCOLT opened in 2008 and is the first large academic adjuvant trial fully conducted in the APAC region. Centrally coordinated by the Trial Management Team at the National Cancer Centre Singapore, it has involved 74 sites across 12 APAC countries/regions, including five middle-income countries.

Results: Challenges encountered included regulatory complexity, communication and logistical barriers, limited funding and resources, disparate experience and infrastructure across sites, recruitment holds because of changes in local laws, patient attrition, and disruptions caused by the COVID-19 pandemic. Over 100 contracts and 49 ethics board reviews were required, contributing to a lengthy prestudy preparation time of 2 years and start-up times of approximately 6 months per site. Some of the mitigating actions included engaging local cooperative groups (eg, the Australasian Gastro-Intestinal Trials Group in Australia and New Zealand) and seven contract research organizations to manage sites, regular communication with the central team, transition to electronic data management, and a centralized drug-dispensing system.

Conclusion: To ensure an efficient and patient-centered clinical trials environment in the APAC region and sustained growth, we suggest coordinated approaches to harmonize regulatory processes, APAC academic oncology trials consortia to streamline processes and provide governance, and ongoing commitment from governments, funding agents, and industry.

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/go/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Figures

FIG 1
FIG 1
ASCOLT trial schema. ASCOLT, Aspirin for Dukes C and high-risk Dukes B Colorectal cancer trial.
FIG 2
FIG 2
Map of participating countries and/or regions.
FIG 3
FIG 3
Timeline of key trial milestones.
See this image and copyright information in PMC

References

    1. Atal I, Trinquart L, Porcher R, et al. Differential globalization of industry- and non-industry–sponsored clinical trials. PLoS One. 2015;10:e0145122. - PMC - PubMed
    1. Leddy L, Sukumar P, O’Sullivan L, et al. An investigation into the factors affecting investigator-initiated trial start-up in Ireland. Trials. 2020;21:962. - PMC - PubMed
    1. Duffett M, Choong K, Foster J, et al. High-quality randomized controlled trials in pediatric critical care: A survey of barriers and facilitators. Pediatr Crit Care Med. 2017;18:405–413. - PubMed
    1. Seruga B, Sadikov A, Cazap EL, et al. Barriers and challenges to global clinical cancer research. Oncologist. 2014;19:61–67. - PMC - PubMed
    1. Ali R, Toh HC, Chia WK. The utility of Aspirin in dukes C and high risk dukes B colorectal cancer—The ASCOLT study: Study protocol for a randomized controlled trial. Trials. 2011;12:261. - PMC - PubMed

Publication types

Associated data